Cardiox Shunt Detection Technology Study

Stopped early · Phase 3

Conditions studied: Patent Foramen Ovale

In brief

The CARDIOX Flow Detection System is designed to detect the presence of indocyanine green (ICG) dye in the blood and is being investigated to establish its efficacy in detecting the presence of right to left cardiac shunt (RTLS). The CARDIOX system will be compared against transesophageal echocardiography (TEE) for sensitivity and specificity, as well as transcranial doppler (TCD) for positive percent agreement and negative percent agreement.

Key facts

Study ID
NCT01333761
Run by
Cardiox Corporation
People needed
71
Starts
2011-04-01
Expected to finish
2012-07-01
Last updated by the study team
2013-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.